131 results on '"Oluwole SF"'
Search Results
2. Breast Cancer in Women with Human Immunodeficiency Virus Infection: Pathological, Clinical, and Prognostic Implications.
- Author
-
Sarhan M, DePaz HA, and Oluwole SF
- Subjects
BREAST cancer prognosis ,ANALYSIS of variance ,BIOMARKERS ,BLACK people ,CANCER invasiveness ,COMPARATIVE studies ,HIV-positive persons ,RESEARCH methodology ,COMORBIDITY - Abstract
Background: AIDS and breast cancer have become two important public health issues for women. Of interest is the prolonged survival of patients diagnosed with HIV infection as a result of the use of highly active antiretroviral therapy (HAART). With improved survival, we are likely to see more HIV-infected patients with breast cancer. Methods: This study, which is a review of our experience at Harlem Hospital Center, New York, between 2000 and 2008, compared HIV-positive with HIV-negative breast cancer patients, with attention to tumor size, stage, grade, molecular markers and lymphovascular invasion, treatment, and patient survival. Results: Only 63 of 370 patients with breast carcinoma were tested for HIV, and 6 of the 63 women tested positive for HIV. We, therefore, compared the clinical features and tumor characteristics seen in the 6 HIV-infected women with those of the 57 HIV-seronegative breast cancer patients. We found no differences in presentation, median age, and tumor morphology in the two groups of patients. When the patients in our previous report on 5 HIV-positive breast cancer patients were added to the present group, the overall 5-year survival rate among the 11 HIV-infected patients was 75%. Of note is the finding that HIV infection in premenopausal women was not associated with aggressive breast cancer subtypes with poor survival outcome. Conclusions: These results demonstrate that histological subgroups and 5-year survival appear similar among HIV-positive breast cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
3. Acquired thymic tolerance to rat islet allorgafts induced by intrathymic administration of soluble alloantigens.
- Author
-
Fiedor, P, M, X Jin, Hardy, MA, and Oluwole, SF
- Published
- 1996
- Full Text
- View/download PDF
4. Pulmonary edema associated with methylene blue dye administration during sentinel lymph node biopsy.
- Author
-
Teknos D, Ramcharan A, and Oluwole SF
- Subjects
- Adult, Female, Humans, Coloring Agents adverse effects, Methylene Blue adverse effects, Pulmonary Edema chemically induced, Sentinel Lymph Node Biopsy
- Abstract
Sentinel lymph node biopsy (SLNB) is an established procedure for staging early breast cancer. Recently, methylene blue dye has been advocated as a safe, efficacious and cost-effective substitute for isosulfan blue in sentinel lymph node mapping. In this case report, we describe a 44-year-old woman who developed pulmonary edema associated with the use of methylene blue dye for SLNB.
- Published
- 2008
- Full Text
- View/download PDF
5. Breast cancer in women with HIV/AIDS: report of five cases with a review of the literature.
- Author
-
Oluwole SF, Ali AO, Shafaee Z, and DePaz HA
- Subjects
- Adult, Breast Neoplasms mortality, Breast Neoplasms therapy, Carcinoma, Ductal, Breast mortality, Carcinoma, Ductal, Breast therapy, Female, Humans, Incidence, Mastectomy, Middle Aged, Survival Rate, Acquired Immunodeficiency Syndrome complications, Breast Neoplasms complications, Carcinoma, Ductal, Breast complications, HIV Infections complications
- Abstract
Background: The association of human immunodeficiency virus (HIV) infection with breast carcinoma is unclear. With improved survival of HIV-infected patients due to better understanding and treatment of the disease, there is likely to be an increase in incidence of breast cancer in women with HIV infection., Methods: The medical records of 305 patients with breast cancer seen between January 1995 and December 2000 at Harlem Hospital Center, New York, where approximately 1,000 HIV-infected patients are treated yearly, were reviewed with attention to age, breast cancer stage at presentation, and patient survival., Results: Breast cancer in the five HIV-infected patients has same median age distribution, disease stage, and pathologic characteristics as in the 300 HIV-indeterminate patients. Four of the five (80%) HIV-infected women compared to 79% in the HIV-indeterminate patients presented with early breast cancer (Stages I and II). Five-year survival in the HIV-infected patients is 80%, which is similar to the observed 70% 5-year crude survival rate in the indeterminate group., Conclusions: Our results do not support the recent reports suggesting that HIV infection is associated with poorly differentiated, aggressive disease with poor survival outcome. It remains unclear if breast carcinoma is directly linked to HIV infection.
- Published
- 2005
- Full Text
- View/download PDF
6. Effect of streptavidin on cardiac allograft prolongation is due to host T-Cell suppression.
- Author
-
Witkowski P, Fawwaz RA, Jin MX, DePaz HA, Oluwole OO, Hardy MA, and Oluwole SF
- Subjects
- Animals, Antilymphocyte Serum therapeutic use, Graft Survival drug effects, Immunosuppressive Agents therapeutic use, Lymphocyte Activation drug effects, Lymphocyte Activation immunology, Lymphocyte Transfusion, Rats, Rats, Inbred Lew, Rats, Inbred WF, Spleen immunology, Spleen radiation effects, T-Lymphocytes drug effects, Transplantation, Homologous immunology, Graft Survival immunology, Heart Transplantation immunology, Streptavidin therapeutic use, T-Lymphocytes immunology
- Abstract
Aim: The aim of this study was to evaluate the effectiveness of streptavidin immunomodulation in the high-responder WF-to-Lewis combination., Methods/results: We examined the effects of streptavidin on the proliferative response of T cells in coculture studies. Two to 200 microg/mL streptavidin significantly (P < .001) suppressed the proliferation of Lewis T cells to WF by 76%-83% compared with untreated responders. Next, we studied the survival of WF cardiac allografts in Lewis recipients pretreated with streptavidin. A 5-day course of peritransplantation recipient treatment with streptavidin doses of 8, 12, 20, 40, and 60 mg/kg combined with single dose of 0.5 mL antilymphocyte serum (ALS) significantly (P < .001) prolonged cardiac allograft survival from MST of 7 +/- 0.5 and 8 +/- 0.5 days in naive and ALS-treated controls to 15 +/- 1, 20 +/- 3, 16 +/- 3, 17 +/- 3, and 23 +/- 2 days, respectively. In contrast, posttransplantation administration of 80 mg/kg streptavidin resulted in animal death, suggesting toxicity of this dose. Additionally, 10 mg/kg or 20 mg/kg streptavidin administration for 10 consecutive days resulted in significant graft prolongation (MST of 18 +/- 1 and 21 +/- 1 days, respectively; P < .001)., Conclusion: Although peritransplantation streptavidin treatment is effective in prolonging rat cardiac allografts in the high-responder WF-to-Lewis combination, it does not induce permanent graft survival as observed in the low-responder combination of Lewis-to-ACI. Our finding of in vitro immunomodulatory effect of streptavidin on T-cell proliferation suggests that its in vivo effect is partly due to prevention of T-cell activation following antigen exposure.
- Published
- 2005
- Full Text
- View/download PDF
7. Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma.
- Author
-
Agrawal S, Reemtsma K, Bagiella E, Oluwole SF, and Braunstein NS
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 2, ATP Binding Cassette Transporter, Subfamily B, Member 3, ATP-Binding Cassette Transporters genetics, Animals, Antigen Presentation genetics, Blotting, Northern, Cytotoxicity Tests, Immunologic, Flow Cytometry, Histocompatibility Antigens Class I immunology, Immunotherapy, Lung Neoplasms genetics, Lung Neoplasms pathology, Male, Melanoma, Experimental genetics, Melanoma, Experimental pathology, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, RNA, Neoplasm chemistry, RNA, Neoplasm genetics, T-Lymphocytes, Cytotoxic, Transfection, ATP-Binding Cassette Transporters immunology, Antigen Presentation immunology, Lung Neoplasms immunology, Melanoma, Experimental immunology
- Abstract
Mutations in transporters associated with antigen processing (TAP-1 and -2) required for the transport of cytosolic endogenous peptides to the endoplasmic reticulum correlate with increased metastatic potential and reduced host survival in several malignancies. To address the possible function of TAP as a "tumor suppressor" gene, we show that correction of TAP-1 and/or TAP-2 defects in B16 mouse melanoma enhanced the cell surface expression of MHC class I molecules and significantly reduced the rate of subcutaneous tumor growth and pulmonary metastatic burden. Cytotoxic assays confirmed increased sensitivity of TAP-1 and/or TAP-2 transfected clones of B16 melanoma to cytotoxic T lymphocytes. These results indicate that the expression of TAP limits the malignant potential of tumors with implications for CD8(+) T cell-based immunotherapy in controlling growth of certain TAP-deficient malignancies.
- Published
- 2004
- Full Text
- View/download PDF
8. New strategies in immune tolerance induction.
- Author
-
Oluwole SF, Oluwole OO, Adeyeri AO, and DePaz HA
- Subjects
- Animals, Antigens chemistry, Chimerism, Dendritic Cells cytology, Humans, Immune System, Immunosuppression Therapy, Isoantigens chemistry, Mice, Models, Biological, Rats, Swine, Thymus Gland metabolism, Immune Tolerance, Organ Transplantation methods
- Abstract
Induction of tolerance in clinical organ transplantation that will obviate the use of chronic immunosuppression and preserve host immune response to other antigens remains the goal of transplant research. The thymus plays a critical role in the ability of the immune system to discriminate between self- and nonself-antigens or harmful and harmless alloantigens. We now know that multiple factors determine how the immune system responds to a self-antigen or foreign antigen. These determinants include developmental stage of the host, stage of T-cell maturity, site of antigen encounter, type and maturity of antigen-presenting cells, and presence and type of costimulatory molecules. Our understanding of the mechanisms of T-cell interactions with peptide/ major histocompatibility complex in peripheral lymphoid organs has led to experiments that translate into peripheral T-cell tolerance. The induction of high-avidity peripheral alloreactive T cells in the early phase of organ transplantation makes it difficult to achieve long-term alloantigen-specific tolerance without the use of transient perioperative immunosuppression. Therefore, protocols that induce robust tolerance in rodent and nonhuman primate models involve the use of donor antigen combined with a short course of perioperative immunosuppression. These studies suggest that the underlying mechanisms of peripheral tolerance include deletion, anergy, immune deviation, and regulatory T cells. This review focuses on recent advances in tolerance induction in experimental animal models and discusses their relevance to the development of protocols for the induction and maintenance of clinical transplant tolerance.
- Published
- 2004
- Full Text
- View/download PDF
9. CD4+CD25+ regulatory T cells mediate acquired transplant tolerance.
- Author
-
Oluwole SF, Oluwole OO, DePaz HA, Adeyeri AO, Witkowski P, and Hardy MA
- Subjects
- Animals, CD4-Positive T-Lymphocytes immunology, Humans, Mice, T-Lymphocyte Subsets immunology, CD4-Positive T-Lymphocytes transplantation, Receptors, Interleukin-2 analysis, T-Lymphocyte Subsets transplantation, Transplantation Tolerance
- Abstract
The Holy Grail of clinical organ transplantation is the safe induction of allograft tolerance. Transplant tolerance has been successfully induced in animal models. Since T cells play a pivotal role in graft rejection, modulating T cell function has been the primary focus of studies aimed at inducing transplant tolerance. Rodent models of transplant tolerance induction include central deletion and peripheral mechanisms involving activation-induced cell death (AICD), anergy, immune deviation, and production of regulatory T cells. These mechanisms are not mutually exclusive. Although clonal deletion and anergy limit self-reactive T cells in the thymus, these mechanisms alone are not sufficient for controlling self-reactive T cells in the periphery. There is now evidence that the adult animal harbors two functionally distinct populations of CD4(+) T cells; one mediates autoimmune disease and the other dominantly inhibits it. The latter cells express CD4, CD25 and CTLA-4. These thymus-derived T cells have recently been shown to mediate the induction and maintenance of transplant tolerance. These CD4(+)CD25(+) T cells are similar in origin, phenotype, and function to those that maintain natural self-tolerance and T cell homeostasis in the periphery. Against this background, is it possible that alloantigen specific regulatory T cells might be generated and expanded ex vivo before organ transplantation and then infused to induce long-term tolerance, perhaps without the need for chronic immunosuppression?
- Published
- 2003
- Full Text
- View/download PDF
10. Role of CD41CD251 regulatory T cells from naive host thymus in the induction of acquired transplant tolerance by immunization with allo-major histocompatibility complex peptide.
- Author
-
Oluwole OO, DePaz HA, Adeyeri A, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Animals, Cell Transplantation, Isoantigens immunology, Kidney surgery, Peptide Fragments immunology, Rats, Rats, Inbred Strains, Thymectomy, Thymus Gland cytology, Transplantation, Heterotopic, Transplantation, Isogeneic, Adoptive Transfer, CD4-Positive T-Lymphocytes physiology, Heart Transplantation immunology, Histocompatibility Antigens immunology, Receptors, Interleukin-2 metabolism, Transplantation Tolerance physiology
- Abstract
Background: Immunization with allo-major histocompatibility complex peptide induces operational tolerance, whereas thymectomy abrogates this effect. We hypothesized that recent thymic emigrants with regulatory function are important in the induction of acquired transplant tolerance in this system., Methods: In this study, we examined the possibility of restoring transplant tolerance to thymectomized (TMX) ACI recipients with concomitant adoptive transfer of syngeneic T cells indirectly primed with a single immunodominant Wistar Furth allo-major histocompatibility complex class I peptide (peptide 5, residues 93-109) and unmodified thymocytes or CD4+CD25+ thymic T cells., Results: Co-transfer of in vivo allopeptide-primed T cells and naive syngeneic thymic T cells on day -7 restored permanent acceptance of cardiac allografts to 70% of transiently antilymphocyte serum-immunosuppressed TMX recipients. Similarly, the adoptive transfer of allopeptide-primed T cells led to 100% donor-specific permanent graft acceptance among transiently antilymphocyte serum-immunosuppressed TMX recipients with renal subcapsular syngeneic thymic grafts. To demonstrate the role of regulatory T cells among new thymic emigrants in the induction of tolerance, we showed that the co-transfer of CD4+CD25+ but not CD4+CD25- thymic T cells with allopeptide-primed syngeneic T cells restored tolerance to TMX recipients. It seems that the induction of transplant tolerance in this system is dependent on the presence of CD4+CD25+ regulatory T cells among the recent thymic emigrants., Conclusions: This study suggests that CD4+CD25+ regulatory T cells specific for the induction of transplant tolerance are similar in origin, phenotype, and function to those involved in the maintenance of self-tolerance and the prevention of autoimmunity.
- Published
- 2003
- Full Text
- View/download PDF
11. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
- Author
-
DePaz HA, Oluwole OO, Adeyeri AO, Witkowski P, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Adoptive Transfer, Animals, Biomarkers, Bone Marrow Cells cytology, Bone Marrow Cells drug effects, Cell Differentiation drug effects, Cell Differentiation immunology, Dendritic Cells drug effects, Flow Cytometry, Graft Rejection immunology, Lymphocyte Culture Test, Mixed, Major Histocompatibility Complex immunology, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Rats, Inbred WF, Transplantation, Homologous, Dendritic Cells cytology, Graft Survival immunology, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Heart Transplantation immunology
- Abstract
Background: Because the differential polarization of T cells in response to antigen presentation is dependent on the maturational state of dendritic cells (DCs), we hypothesized that the adoptive transfer of immature myeloid DCs (iMDCs) would prolong graft survival., Methods: To evaluate this hypothesis, we studied the effects of transfer of iMDCs and mature myeloid DCs (mMDCs) on rat cardiac allograft survival., Results: Whereas iMDCs that do not express costimulatory molecules induce allogeneic T-cell hyporesponsiveness in coculture studies, mMDCs that express high levels of major histocompatibility complex class II costimulatory and maturation molecules induce a robust allostimulatory T-cell response. Adoptive transfer of Wistar Furth iMDCs, unlike mMDCs, 7 days before cardiac transplantation significantly prolonged graft survival. It was important that adoptive transfer of iMDCs combined with 0.5 mL antilymphocyte serum (ALS) transient immunosuppression on day -7 led to donor-specific permanent graft survival in 50% of recipients. In contrast, adoptive transfer of mMDCs combined with ALS led to graft survival similar to that in recipients treated with ALS alone. Stimulation of CD4 T cells isolated from the spleen of unresponsive allograft recipients with donor antigen resulted in donor-specific hyporesponsiveness and production of interleukin (IL)-10 and transforming growth factor-beta but not IL-4 and interferon-gamma. The tolerant T-cell unresponsiveness was reversed by the addition of IL-2., Conclusion: Our data confirming the immunoregulatory effect of immature DCs indicate that induction of transplant tolerance by iMDCs is partly dependent on in vivo generation of regulatory T cells. This finding suggests that immunization with immature donor DCs has therapeutic potential for the induction of transplant tolerance and treatment of autoimmune diseases.
- Published
- 2003
- Full Text
- View/download PDF
12. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community.
- Author
-
Oluwole SF, Ali AO, Adu A, Blane BP, Barlow B, Oropeza R, and Freeman HP
- Subjects
- Adenocarcinoma economics, Adenocarcinoma epidemiology, Adenocarcinoma therapy, Adolescent, Adult, Aged, Aged, 80 and over, Breast Neoplasms economics, Breast Neoplasms epidemiology, Breast Neoplasms therapy, Female, Health Services Accessibility economics, Humans, Male, Medically Uninsured statistics & numerical data, Middle Aged, Neoplasm Staging, New York City epidemiology, Socioeconomic Factors, Survival Analysis, Urban Population, Adenocarcinoma diagnosis, Breast Neoplasms diagnosis, Mass Screening statistics & numerical data, Medically Underserved Area, Outpatient Clinics, Hospital statistics & numerical data
- Abstract
Background: Our previous report showed that the disparity in breast carcinoma survival between black and white women because of advanced stage of disease at presentation in poor black women is related to their low socioeconomic status and lack of health insurance. This observation led to establishment of a community-oriented free cancer screening service., Study Design: To evaluate the impact of screening on breast cancer stage at diagnosis, analysis of data from the Harlem Hospital Tumor Registry between 1995 and 2000 was performed and compared with our 1964-1986 report., Results: Twenty-three percent of cancers (324 of 1,405) diagnosed between 1995 and 2000 were breast carcinoma. Data confirm that lack of insurance remains a major problem among poor black women. We observed a marked fall, from 49% in our earlier report to 21% in this study, in late-stage (III and IV) disease at presentation. This fall is associated with significant (p < 0.001) improvement in early detection of breast cancer, with 41% of cancers in stages 0 and I in this data compared with 6% in the previous study. Of note, 53% of women with breast carcinoma had breast-conserving surgery and 45% had modified radical mastectomy in this study; 71% had radical or modified radical mastectomy in the earlier report., Conclusions: This study confirms the importance of a free cancer screening program in the improvement of early-stage breast cancer detection, treatment, and survival in a poor urban community.
- Published
- 2003
- Full Text
- View/download PDF
13. Peritransplant streptavidin recipient treatment prolongs rat cardiac allograft survival.
- Author
-
Fawwaz RA, Oluwole OO, DePaz HA, Jin MX, Wang TS, Hardy MA, and Oluwole SF
- Subjects
- Animals, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Rats, Inbred WF, Transplantation, Homologous, Weight Loss, Graft Survival drug effects, Heart Transplantation, Streptavidin therapeutic use
- Abstract
Background: Because streptavidin shows high localization in inflamed tissues, it might also interfere with the proliferation of cells involved in allograft rejection., Methods and Results: Treatment of naïve ACI recipients with 20 mg/kg streptavidin i.p. alone significantly prolonged Lewis cardiac allografts from a mean survival time of 9.8+/-0.7 days in controls to 19.8+/-6.5 days, with one recipient accepting the graft permanently (>250 days). Peritransplant streptavidin treatment combined with 0.5 ml of antilymphocyte serum (ALS) transient immunosuppression led to permanent graft survival (>250 days) in 6 of 10 recipients. Second-set skin grafts performed 60 days after the primary cardiac allograft were prolonged to 45 days, whereas the third party Wistar-Furth (WF) skin grafts were rejected in 15 days without the rejection of the primary Lewis cardiac allografts. Pathology of transplanted cardiac allografts at 100 days showed no mononuclear cell infiltration or chronic allograft vasculopathy. Streptavidin given for 5 days at 20 mg/kg caused a moderate initial weight loss but had no effect on hematologic, biochemical, and histologic parameters in the treated recipients., Conclusion: This study demonstrates that peritransplant recipient treatment with streptavidin combined with peritransplant ALS induces prolonged cardiac and second-set skin allograft survival. We conclude that recipient peritransplant streptavidin treatment may provide a new strategy for the induction of transplant tolerance.
- Published
- 2002
- Full Text
- View/download PDF
14. Role of reentry of in vivo alloMHC peptide-activated T cells into the adult thymus in acquired systemic tolerance.
- Author
-
Gopinathan R, DePaz HA, Oluwole OO, Ali AO, Garrovillo M, Engelstad K, Hardy MA, and Oluwole SF
- Subjects
- Animals, Dendritic Cells immunology, Indium Radioisotopes, Kinetics, Lymphocyte Activation, Organometallic Compounds, Rats, Rats, Inbred ACI, Rats, Inbred WF, Spleen immunology, Transplantation, Isogeneic immunology, Adoptive Transfer, Immune Tolerance physiology, Major Histocompatibility Complex immunology, Oxyquinoline analogs & derivatives, T-Lymphocytes immunology, Thymus Gland immunology, Transplantation, Homologous immunology
- Abstract
Background: T cell recognition of alloMHC peptide presented by self dendritic cells via the indirect pathway of allorecognition in the thymus induces T cell tolerance. Most recently we have shown that the i.v. administration of immunodominant Wistar Furth MHC class I (RT1.Au) peptide 5- (P5) pulsed myeloid or lymphoid dendritic cells induces operational tolerance to a fully MHC-mismatched cardiac allograft. This finding led us to hypothesize that circulation of peripheral P5-activated T cells to the thymus plays an important role in the induction of acquired tolerance., Methods: We used the adoptive transfer of 111Indium-oxine- (111In-oxine) labeled P5-pulsed syngeneic dendritic cells and in vivo P5-activated syngeneic T cells to study the role of their circulation to the thymus in the induction of transplantation tolerance., Results: Intravenously administered 111In-oxine-labeled naïve DC actively migrated to and localized in the liver and spleen but did not enter the lymph nodes, bone marrow, and thymus. In vitro peptide-pulsed dendritic cells had a similar pattern of tissue localization except for a modest number of myeloid but not lymphoid DC entering the thymus. The demonstration that adoptive transfer of in vivo peptide-primed T cells induces permanent graft survival in antilymphocyte serum transiently immunosuppressed syngeneic secondary hosts led us to examine the traffic of in vivo activated T cells. Whereas naïve syngeneic T cells preferentially homed to the peripheral lymphoid organs, they did not reenter the thymus. In contrast, in vivo peptide-activated peripheral T cells migrated to and accumulated in the thymus, thus confirming that reentry of T cells to the thymus is restricted to in vivo activated T cells. Although antilymphocyte serum immunosuppression significantly reduced circulation of primed T cells to the thymus, it did not completely abolish it, as seen with gamma-irradiated primed T cells., Conclusion: These findings provide the first formal evidence directly linking reentry of in vivo alloMHC peptide-activated T cells to the thymus with the induction and possibly maintenance of acquired antigen-specific tolerance. Our results suggest that the thymus is open to a two-way traffic with the periphery and may function as a repository of immunological memory.
- Published
- 2001
- Full Text
- View/download PDF
15. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells.
- Author
-
Garrovillo M, Ali A, Depaz HA, Gopinathan R, Oluwole OO, Hardy MA, and Oluwole SF
- Subjects
- Adoptive Transfer, Animals, Bone Marrow Cells cytology, Bone Marrow Cells immunology, Cells, Cultured, Dendritic Cells immunology, Lymphocyte Activation, Lymphocyte Culture Test, Mixed, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Rats, Inbred WF, T-Lymphocytes immunology, Thymectomy, Thymus Gland cytology, Thymus Gland immunology, Transplantation, Homologous immunology, Dendritic Cells transplantation, Heart Transplantation immunology, Immune Tolerance, Immunosuppression Therapy methods, Isoantigens immunology, Lymphocyte Transfusion, Transplantation Immunology physiology
- Abstract
We have studied the effects of adoptive transfer of host thymic dendritic cells pulsed with immunodominant WF Class I peptide 5 (residues 93-109) on cardiac allograft survival in the WF-to-ACI rat combination. Our results showed that, whereas intrathymic inoculation of WF peptide 5-pulsed ACI thymic dendritic cells alone on day -7 did not prolong graft survival, similar treatment combined with 0.5 mL antilymphocyte serum (ALS) led to 100% permanent acceptance (> 200d) of donor-specific cardiac allografts. Extension of our study to systemic administration of peptide 5-pulsed host thymic dendritic cells confirmed that intravenous injection of peptide 5-pulsed self thymic dendritic cells combined with ALS transient immunosuppression resulted in 100% permanent donor-specific graft survival (> 200d). These results were reproducible in a clinically relevant model using intravenous injection of peptide-pulsed host myeloid dendritic cells. In contrast, thymectomy prior to adoptive transfer of peptide-pulsed host dendritic cells resulted in acute graft rejection at times equivalent to rejection in thymectomized controls. The long-term unresponsive recipients challenged with second-set grafts accepted permanently (> 100d) donor-type (WF) but not third party (Lewis) cardiac allografts. This study suggests that intravenous administration of genetically engineered dendritic cells expressing donor MHC molecules has the potential of inducing transplant tolerance.
- Published
- 2001
16. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.
- Author
-
Oluwole OO, Depaz HA, Gopinathan R, Ali A, Garrovillo M, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Animals, Biomarkers, Bone Marrow Cells immunology, Cell Separation, Diabetes Mellitus, Type 1 immunology, Diabetes Mellitus, Type 1 therapy, Disease Models, Animal, Flow Cytometry, Lymphocyte Culture Test, Mixed, Rats, Thymectomy, Adoptive Transfer, Dendritic Cells immunology, Immune Tolerance, Islets of Langerhans immunology, Islets of Langerhans Transplantation immunology, T-Lymphocytes physiology, Thymus Gland immunology
- Abstract
Pancreatic islet transplantation remains a promising approach to the treatment of type 1 diabetes. Unfortunately, graft failure continues to occur because of immunologic rejection, despite the use of potent immunosuppressive agents. It is therefore reasoned that induction of peripheral tolerance by the use of self-dendritic cells (DCs) as a vehicle to deliver specific target antigens to self-T-cells without ex vivo manipulation of the recipient is an attractive strategy in the treatment of type 1 diabetes. The finding that intrathymic inoculation of an immunodominant WF major histocompatibility complex (MHC) Class I (RT1.A(u)) peptide five (P5) or P5-pulsed host myeloid DCs induces acquired thymic tolerance raises the possibility that adoptive transfer of allopeptide-primed host myeloid or lymphoid DCs might induce transplant tolerance. To address this hypothesis, we studied the effects of intravenous transfer of in vitro P5-pulsed syngeneic myeloid DCs or in vivo P5-primed syngeneic lymphoid (thymic) DCs on islet survival in the WF-to-ACI rat combination. In vivo primed thymic DCs isolated from ACI rats given intrathymic inoculation of P5 for 2 days were capable of in vitro restimulation of in vivo P5-primed T-cells (memory cells). In the first series of studies, we showed that intravenous-like intrathymic-inoculation of in vitro P5-pulsed host myeloid DCs induced donor-specific permanent acceptance of islets in recipients transiently immunosuppressed with antilymphocyte serum (ALS). We next examined whether thymic DCs isolated from animals that had been previously intrathymically inoculated with P5 could induce T-cell tolerance. The results showed that intravenous adoptive transfer of in vivo P5-primed thymic DCs led to donor-specific permanent acceptance of islets in recipients transiently immunosuppressed with ALS. This finding suggested that the thymic DCs take up and present P5 to developing T-cells to induce T-cell tolerance, thus providing evidence of a direct link between indirect allorecognition and acquired thymic tolerance. The second series of studies examined the mechanisms involved in this model by exploring whether in vivo generation of peptide-specific alloreactive peripheral T-cells by intravenous inoculation of P5-pulsed self-DCs was responsible for the induction of T-cell tolerance. Intrathymic inoculation of splenic T-cells obtained from syngeneic ACI rats primed with intravenous injection of P5-pulsed DCs with a high in vitro proliferative response to P5 in the context of self-MHC induced donor-specific permanent acceptance of islets from WF donors. In addition, the clinically relevant model of intravenous injection of P5-activated T-cells combined with transient ALS immunosuppression similarly induced transplant tolerance, which was then abrogated by thymectomy of the recipient before intravenous injection of the activated T-cells. These data raise the possibility that circulation of peptide-activated T-cells to the host thymus plays a role in the induction and possibly the maintenance of T-cell tolerance in this model. Our findings suggest that intravenous administration of genetically engineered host DCs expressing alloMHC peptides might have therapeutic potential in clinical islet transplantation for the treatment of autoimmune diabetes.
- Published
- 2001
- Full Text
- View/download PDF
17. Mechanisms of acquired thymic tolerance: induction of transplant tolerance by adoptive transfer of in vivo allomhc peptide activated syngeneic T cells.
- Author
-
Ali A, Garrovillo M, Oluwole OO, Depaz HA, Gopinathan R, Engelstad K, Hardy MA, and Oluwole SF
- Subjects
- Animals, Heart Transplantation immunology, Isoantigens immunology, Major Histocompatibility Complex, Peptide Fragments immunology, Peptide Fragments pharmacology, Rats, Rats, Inbred Strains, T-Lymphocytes drug effects, T-Lymphocytes immunology, T-Lymphocytes transplantation, Thymectomy, Thymus Gland cytology, Transplantation Immunology, Transplantation, Isogeneic, Adoptive Transfer, Dendritic Cells transplantation, Immune Tolerance physiology, Thymus Gland immunology
- Abstract
Background: Our most recent observation that i.v. injection of Wistar-Furth (WF) major histocompatibility complex Class I peptide 5 (P5)-pulsed self-myeloid or lymphoid dendritic cells (DC) induces transplantation tolerance suggests that adoptive transfer of in vivo allopeptide-primed host T cells might induce acquired tolerance through their interaction with thymic DC., Methods: To examine this hypothesis, host myeloid DC cultured in rat granulocyte/macrophage colony stimulating factor and interleukin 4 were pulsed in vitro with P5 and injected intravenously into syngeneic ACI rats. The T cells primed to P5 via the indirect pathway of allorecognition were harvested 7 days later and administered by either intravenously or intrathymically into syngeneic ACI recipients of WF cardiac allografts., Results: Syngeneic T cells obtained from the spleen of P5-primed rats had a high mixed lymphocyte reaction proliferative response to P5 presented by self-DC. I.v. administration of 2x107 P5-primed alloreactive purified host splenic T cells alone on day -7 significantly (P<0.001) prolonged cardiac allograft survival from 10.5+/-1.0 days to 18.6+/-1.8 days in the WF-to-ACI rat combination. I.v. injection of P5-activated host T cells combined with 0.5 ml antilymphocyte serum (ALS)-transient immunosuppression on day -7 led to 100% donor-specific permanent graft survival (>200 days). Thymectomy before i.v. injection of P5-activated syngeneic T cells led to acute graft rejection, suggesting that the homing of in vivo activated T cells to the host thymus might play a role in the induction of tolerance. To further define the role of the recipient thymus in this model, we examined the effects of intrathymic (i.t.) injection of P5-primed alloreactive T cells on graft survival and found that i.t. administration of the P5-primed T cells on day -7 alone significantly prolonged graft survival (15.0+/-0.7 days) and when combined with 0.5 ml ALS led to donor-specific permanent graft survival. The long-term unresponsive recipients permanently (>100 days) accepted second-set donor-specific cardiac allografts but not third-party (Lewis) grafts., Conclusions: These findings demonstrate that the adoptive transfer of splenic T cells primed to an indirectly presented donor peptide induces transplantation tolerance in a transiently immunosuppressed secondary syngeneic recipient. Our data suggest that the interaction of thymic DC with activated peripheral T cells induces alloantigen (Ag)-specific T-cell tolerance by either inactivation or deletion of alloreactive T cells in the thymus. This observation provides the first formal evidence that the interaction between thymic DC and activated peripheral T cells that continuously circulate through the thymus plays an important role in the induction and maintenance of Ag-specific tolerance.
- Published
- 2001
- Full Text
- View/download PDF
18. Induction of acquired tolerance to cardiac allografts by adoptive transfer of in vivo allopeptide activated T cells.
- Author
-
Ali AO, Garrovillo M, Oluwole OO, DePaz HA, Gopinathan R, Hardy MA, and Oluwole SF
- Subjects
- Animals, Dendritic Cells immunology, Lymphocyte Activation, Rats, Rats, Inbred ACI, T-Lymphocytes immunology, Thymus Gland immunology, Transplantation, Homologous, Adoptive Transfer methods, Dendritic Cells transplantation, Heart Transplantation immunology, T-Lymphocytes transplantation, Transplantation Tolerance
- Published
- 2001
- Full Text
- View/download PDF
19. Regulatory role of the thymic dendritic cells in acquired thymic tolerance: induction of tolerance to cardiac allografts by adoptive transfer of allopeptide-pulsed host thymic dendritic cells.
- Author
-
Garrovillo M, Ali AO, DePaz HA, Gopinathan R, Oluwole OO, Hardy MA, and Oluwole SF
- Subjects
- Adoptive Transfer methods, Animals, Dendritic Cells transplantation, Graft Rejection, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Dendritic Cells immunology, Heart Transplantation immunology, T-Lymphocytes immunology, Thymus Gland cytology, Thymus Gland immunology, Transplantation Tolerance immunology
- Published
- 2001
- Full Text
- View/download PDF
20. Mechanisms of acquired tolerance induced by adoptive transfer of MHC-specific alloreactive T cells: effector T cells migrate to the thymus.
- Author
-
Gopinathan R, DePaz HA, Oluwole OO, Engelstad K, Ali AO, Garrovillo M, Fawwaz RA, Wang TS, Hardy MA, and Oluwole SF
- Subjects
- Animals, Cell Movement, Dendritic Cells immunology, Immunity, Cellular, Rats, Adoptive Transfer, Dendritic Cells transplantation, T-Lymphocytes immunology, Thymus Gland immunology, Transplantation Tolerance immunology
- Published
- 2001
- Full Text
- View/download PDF
21. Thymic recognition of AlloMHC peptide-primed alloreactive T cells induces specific unresponsiveness to islets.
- Author
-
Oluwole OO, DePaz HA, Gopinathan R, Jin MX, Ali AO, Hardy MA, and Oluwole SF
- Subjects
- Adoptive Transfer methods, Animals, Dendritic Cells immunology, Injections, Intravenous, Islets of Langerhans Transplantation immunology, Rats, Rats, Inbred ACI, T-Lymphocytes transplantation, Dendritic Cells transplantation, Histocompatibility Antigens Class I immunology, Thymus Gland immunology, Transplantation Tolerance
- Published
- 2001
- Full Text
- View/download PDF
22. Induction of acquired tolerance by adoptive transfer of in vivo allopeptide primed alloreactive host T cells.
- Author
-
Ali A, Garrovillo M, Oluwole O, Gopinathan R, DePaz HA, and Oluwole SF
- Published
- 2000
- Full Text
- View/download PDF
23. Primary torsion of the greater omentum.
- Author
-
al-Husaini H, Onime A, and Oluwole SF
- Subjects
- Female, Humans, Infarction diagnosis, Middle Aged, Torsion Abnormality, Omentum blood supply, Peritoneal Diseases diagnosis
- Abstract
Primary omental torsion is a rare cause of acute abdominal pain. A case of omental torsion in a 49-year-old woman who presented with clinical features consistent with acute appendicitis is discussed with a review of the literature.
- Published
- 2000
24. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells.
- Author
-
Ali A, Garrovillo M, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Animals, Antibody Affinity, Epitopes, Graft Survival, Heart Transplantation, Histocompatibility Antigens Class I, Immune Tolerance, Islets of Langerhans cytology, Islets of Langerhans Transplantation immunology, Lymphocyte Culture Test, Mixed, Rats, Rats, Inbred ACI, Rats, Inbred BN, Rats, Inbred WF, Dendritic Cells immunology, Thymus Gland immunology
- Abstract
Background: As T-cell receptor-major histocompatibility complex (MHC) class I/self peptide interaction regulates T-cell development in the thymus, we reasoned that presentation of peptides by self dendritic cells (DC) to developing T cells in the thymus might induce acquired thymic tolerance. This hypothesis is based on the finding that intrathymic injection of allopeptides in the adult animal induces acquired tolerance. To examine this hypothesis, we studied the effects of intrathymic (IT) injection of a single immunodominant Wistar-Furth (WF) MHC class I (RT1.Au) peptide-pulsed host DC on islet allograft survival in the WF-to-ACI rat combination., Methods: Bone marrow-derived ACI DC expressing MHC class I and II, OX62, and ED2 present allopeptides to naive and specifically peptide-primed syngeneic T cells in mixed lymphocyte reaction. Host DC pulsed with RT1.Au peptide 5 (residues 93-109) were injected into the thymus of streptozotocin-induced diabetic ACI that were transplanted 7 days later with donor-type (WF) or third-party (Brown Norway [BN]) islets., Results: Whereas IT injection of 300 microg of peptide 5 alone led to normoglycemia and permanent islet survival in three of six diabetic ACI recipients, similar treatment combined with simultaneous intraperitoneal injection of 0.5 ml of anti-lymphocyte serum (ALS) on day -7 led to 100% permanent islet allograft survival (>200 days) compared to a mean survival time of 15.0+/-2.3 days in controls treated with ALS alone. In contrast, similarly prepared animals rejected the third-party (BN) islets in an acute fashion. To address the question of indirect allorecognition in acquired thymic tolerance, we examined the effect of peptide-pulsed host DC on graft survival. Whereas IT injection of peptide-pulsed host DC alone resulted in permanent islet survival in two of five animals, IT injection of peptide-pulsed host DC combined with 0.5 ml of ALS induced 100% donor-specific permanent islet allograft survival in the WF-to-ACI rat combination. These results suggest that thymic DC take up, process, and present the administered peptide to the developing T cells by the indirect allorecognition pathway in the induction of acquired thymic tolerance., Conclusion: We have demonstrated a novel approach to inducing transplant tolerance to islet allografts with IT injection of allopeptide-pulsed host DC. This finding suggests that immunization strategies using DC expressing MHC allopeptides or peptide analogue might be potentially useful in the treatment of autoimmune diabetes mellitus.
- Published
- 2000
- Full Text
- View/download PDF
25. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
- Author
-
Garrovillo M, Ali A, and Oluwole SF
- Subjects
- Animals, Antigens, Surface analysis, Bone Marrow Cells cytology, Bone Marrow Cells immunology, Cells, Cultured, Dendritic Cells cytology, Dendritic Cells transplantation, Graft Survival immunology, Histocompatibility Antigens Class I immunology, Peptide Fragments immunology, Rats, Rats, Inbred Lew, Rats, Inbred WF, Dendritic Cells immunology, Heart Transplantation immunology, Immune Tolerance physiology, Isoantigens immunology, T-Lymphocytes immunology, Thymus Gland immunology
- Abstract
Background: Presentation of peptides either by recipient or donor MHC molecules displayed on the surface of antigen-presenting cells is an essential element in the induction of T cell responses to transplant antigens. The finding that intrathymic (IT) injection of an immunodominant peptide induces acquired thymic tolerance suggests an indirect pathway of allorecognition in the thymus. To address this theory, we studied the effects of IT injection of host bone marrow (BM)-derived dendritic cells (DC)-pulsed with the immunodominant Wistar Furth (WF) MHC class I (RT1.Au) peptide 5 (93-109) on cardiac allograft survival in the WF-to-ACI rat combination., Methods: DC were propagated from cultures of ACI (recipient) bone marrow (BM) maintained in a medium supplemented with granulocyte-macrophage colony-stimulating factor and IL-4. The BM-derived DC after 8 days of culture were pulsed in vitro with a single WF MHC class I peptide (Residue 93-109) with the dominant epitope, washed, and injected into the thymus of ACI rats. The ACI recipients received donor-type (WF) or 3rd party (Lewis) cardiac allografts 7 days after IT immunization with peptide-pulsed DC., Results: BM-derived DC cultured in granulocyte-macrophage colony-stimulating factor and interleukin-4 for 8 days have a strong allostimulatory ability and present peptide 5 to naive syngeneic T cells in mixed lymphocyte reaction. IT inoculation of 300 microg RT1.Au peptide 5 combined with transient antilymphocyte serum immunosuppressive therapy induced donor-specific tolerance to cardiac allografts. Extension of this finding to peptide-pulsed self DC showed that IT injection of peptide 5-pulsed host DC consistently led to permanent acceptance (>150 days) of donor-type (WF) cardiac allografts, whereas third-party (Lewis) grafts were acutely rejected. The long-term unresponsive recipients challenged with second-set grafts accepted permanently (>100 days) donor-type(WF) grafts while rejecting third-party (Lewis) grafts without the rejection of the primary WF grafts., Conclusion: This novel finding that allopeptide-pulsed host DC induces tolerance to cardiac allografts suggests that the induction of acquired tolerance is dependent on the indirect allorecognition pathway. The results further suggest that genetically engineered DC expressing donor MHC class I or II molecules or a peptide analogue might have therapeutic potential in the induction of transplant tolerance and in the treatment of autoimmune diseases.
- Published
- 1999
- Full Text
- View/download PDF
26. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments.
- Author
-
Oluwole SF, Chowdhury NC, Ingram M, Garrovillo M, Jin MX, and Agrawal S
- Subjects
- Animals, Cytokines physiology, Down-Regulation, Gene Expression, Graft Rejection genetics, Graft Survival, Heart Transplantation immunology, Histocompatibility Antigens Class I immunology, Immune Tolerance immunology, Immunodominant Epitopes, Interferon-gamma genetics, Interleukin-10 genetics, Interleukin-2 genetics, Interleukin-4 genetics, RNA, Messenger metabolism, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Rats, Inbred WF, Th1 Cells metabolism, Th2 Cells metabolism, Histocompatibility Antigens Class I pharmacology, Thymus Gland immunology
- Abstract
Background: We have recently shown that intrathymic injection of a combination of immunogenic WAG-derived or Wistar-Furth (WF) (RT1.Au) major histocompatibility complex class I peptides induces acquired systemic tolerance to cardiac and islet allografts in the WF-to-ACI rat combination and therefore hypothesized that identification of the class I peptide dominance may play an important role in the induction of antigen (Ag)-specific tolerance. This study defined the peptide with the dominant epitope among the seven synthetic RT1.Au peptides and analyzed the immunoregulatory cytokines within the lymphoid and intragraft compartments associated with acquired thymic tolerance., Methods: ACI recipients were pretreated with intrathymic (IT) injection of 300 microg of the individual seven RT1.Au peptides 7 days before WF or Lewis cardiac transplantation. Cytokine profile of mixed lymphocyte reaction supernatants of T cells obtained from the thymus, mesenteric lymph nodes, spleen, peripheral blood leukocytes, and graft infiltrating cells after donor (WF) or third-party (Lewis) Ag stimulation were measured by enzyme-linked immunosorbent assay, whereas cytokine gene expression was determined by reverse transcription-polymerase chain reaction., Results: Only IT injection of peptide 5 (93-109) among the seven RT1.Au peptides induced donor-spe cific tolerance to cardiac allografts in the WF-to-ACI rat combination. In addition, intravenous injection of peptide 5 did not prolong WF graft survival in ACI recipients. Analysis of cytokine production by the tolerant recipients showed significant Ag-specific reduction in the production of interleukin (IL)-2 and interferon-gamma (IFN-gamma) in the thymus, mesenteric lymph nodes, spleen, and peripheral blood leukocytes, which was not associated with a concomitant Ag-specific increase in IL-4 and IL-10 production. Measurement of cytokine mRNA expression confirmed undetectable
- Published
- 1999
- Full Text
- View/download PDF
27. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
- Author
-
Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, and Oluwole SF
- Subjects
- Animals, Blood Glucose, Diabetes Mellitus, Experimental immunology, Diabetes Mellitus, Experimental surgery, Graft Survival drug effects, Graft Survival immunology, Male, Peptide Fragments immunology, Peptide Fragments pharmacology, Rats, Rats, Inbred WF, Spleen cytology, Spleen immunology, Transplantation, Homologous, Histocompatibility Antigens Class I pharmacology, Immune Tolerance drug effects, Islets of Langerhans Transplantation immunology, T-Lymphocytes immunology, Thymus Gland immunology
- Abstract
Although transplantation remains the treatment of choice for diabetes mellitus, immunological rejection of allografts continues to be a major problem. The search for strategies to prevent graft rejection led us to examine if the fate of developing T cells may be influenced by the presence of allo MHC class I peptides in the thymus because T cell receptor-MHC class I/self-peptide interaction regulates thymocyte development. We studied the effects of intrathymic (IT) injection of a short segment of a synthetic immunogenic MHC class I peptide (peptide 2, residues 67-85) of the hypervariable domain of RT1.A derived from WAG rat (RT1U) on islet graft survival in the WF(RT1U)-to-ACI combination. Adult diabetic male recipients were treated with IT injection of a single WAG-derived MHC class I peptide 7 days before intraportal islet transplantation. Long-term unresponsive islet recipients were examined for the development of alloantigen (Ag)-specific regulatory cells. The results showed that while IT injection of 150 microg peptide 2 on day -7 did not prolong graft survival in naive recipients [median survival time (MST) of 14.0 days vs. 9.6 in controls], IT injection of 300 or 600 microg peptide 2 led to normoglycemia and permanent islet survival (> 200 days) in 4/6 and 3/5 STZ-induced diabetic ACI recipients, respectively. IT injection of 150, 300, or 600 microg peptide 2 combined with 0.5 antilymphocyte serum (ALS) immunosuppression on day -7 led to 100% permanent islet allograft survival (> 200 days) compared to MST of 15.0 +/- 2.3 days in ALS alone-treated controls. Similarly prepared animals rejected third-party Brown Norway (BN) islets in an acute fashion, thus demonstrating donor specificity. Intravenous injection of 300 microg peptide 2 combined with 0.5 ml ALS did not prolong islet allograft survival. The long-term unresponsive islet allograft recipients challenged with second set grafts accepted permanently 100% donor-type cardiac allografts while rejecting third-party (BN) hearts without rejecting the primary Wistar Furth (WF) islets. In analyzing the underlying mechanisms of acquired systemic tolerance, we found no suppressor/regulatory cells in adoptive transfer studies in tolerant animals at 30 days after IT injection of allopeptides. In contrast, adoptive transfer of 5 x 10(7) unseparated spleen cells from tolerant animals at 60 and 100 days after islet transplantation into lightly irradiated [200 rad total body irradiation (TBI)] ACI recipients led to donor-specific permanent islet graft survival in 2/3 and 4/5 secondary recipients, respectively, compared to an MST of 13.8 days in lightly irradiated ACI given unmodified syngeneic spleen cells. In addition, adoptive transfer of 2 x 10(7) purified T cells obtained from long-term functioning islet recipients led to permanent donor-specific islet survival in secondary recipients. The finding that IT injection of a short segment of a synthetic immunodominant MHC class I peptide derived from WAG that shares the RT1.A(U) domain with the graft donor is capable of inducing acquired systemic tolerance to WF islets suggests that linked recognition or epitope suppression may be involved in the induction of unresponsiveness. Generation of peripheral Ag-specific regulatory cells that suppress Ag-specific alloreactive T cells is, in part, responsible for the maintenance of tolerance in this model.
- Published
- 1999
- Full Text
- View/download PDF
28. Maintenance of acquired thymic tolerance to rat islet allografts by regulatory/suppressor T cells.
- Author
-
Saborio DV, Chowdhury NC, Hardy MA, and Oluwole SF
- Subjects
- Animals, Antilymphocyte Serum therapeutic use, Diabetes Mellitus, Experimental surgery, Graft Survival immunology, Histocompatibility Antigens Class I chemistry, Peptide Fragments immunology, Rats, Rats, Inbred ACI, Rats, Inbred Strains, Rats, Inbred WF, Thymus Gland immunology, Histocompatibility Antigens Class I immunology, Immunosuppression Therapy methods, Islets of Langerhans Transplantation immunology, Peptide Fragments therapeutic use, T-Lymphocytes, Regulatory immunology
- Published
- 1999
- Full Text
- View/download PDF
29. Tuberculous orchitis co-existing with tuberculosis of the sternum--case report.
- Author
-
Fadiran OA, Akintan B, and Oluwole SF
- Subjects
- Adult, Antitubercular Agents therapeutic use, Humans, Male, Orchitis drug therapy, Orchitis microbiology, Tuberculosis, Male Genital drug therapy, Tuberculosis, Osteoarticular drug therapy, Orchitis complications, Sternum, Tuberculosis, Male Genital complications, Tuberculosis, Osteoarticular complications
- Abstract
The sternum and testis are infrequent localisations for extra pulmonary tuberculosis. The initial response to a co-existing lesion, as this case depicted is, to implicate a malignant process of some sort. A high index of suspicion is needed to overcome this diagnostic riddle. Biopsy of the lesion and bacteriological work-up are essential ingredients of management.
- Published
- 1999
- Full Text
- View/download PDF
30. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
- Author
-
Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, and Oluwole SF
- Subjects
- Animals, Cytokines biosynthesis, Cytotoxicity, Immunologic immunology, Graft Survival immunology, Heart Transplantation immunology, Injections, Islets of Langerhans Transplantation, Lymphocytes immunology, Rats, Rats, Inbred ACI immunology, T-Lymphocytes metabolism, Histocompatibility Antigens immunology, Immune Tolerance immunology, Isoantigens immunology, Peptide Fragments immunology, Rats, Inbred Strains immunology, Rats, Inbred WF immunology, Thymus Gland immunology
- Abstract
Background: Because T cell receptor-MHC class I/self-peptide interactions regulate T-cell development, the presence of MHC allopeptides in the thymus may influence T-cell tolerance to alloantigens. This hypothesis is supported by our most recent finding that intrathymic (IT) inoculation of nonimmunogenic synthetic peptides derived from "WAG" RT1.A induces tolerance to cardiac allografts in the Wistar-Furth (WF)-to-ACI model. To evaluate whether in vivo immunogenicity of MHC peptides is relevant to tolerance induction and to examine the effect of peptide specificity, we compared the effects on graft survival of well-defined, strain-specific immunogenic WF MHC class I peptides (RT1.AU) with closely related but non-strain-specific class I peptides derived from WAG (RT1U)., Methods: In vivo immunization of seven MHC class I peptides synthesized from RT1.AU sequences showed that two (u-5 and u-7) were immunogenic, whereas five others were not immunogenic in ACI recipients. We then examined the effects on cardiac allograft survival in the WF-to-ACI model of the two immunogenic RT1.AU peptides (u-5 and u-7) and three immunogenic WAG-derived peptides (peptides 1, 2, and 5)., Results: A combination of equal amounts (150 microg or 300 microg) of u-5 or u-7 each with 0.5 ml of antilymphocyte serum (ALS) on day -7 led to 60% and 100% permanent graft survival (>150 days), respectively. IT injection of the individual peptides on day -7 showed that only 300 microg of u-5 significantly prolonged graft survival to a median survival time of 17.3 days from 10.5 days in naive recipients. IT injection of 150, 300, and 600 microg of u-5 combined with 0.5 ml of ALS on day -7 led to permanent graft survival (> 150 days) in four of six, nine of nine, and six of six ACI recipients, respectively, compared with a median survival time of 15.4 days in ALS alone-treated controls. In contrast, similar treatments with peptide u-7 with or without 0.5 ml of ALS did not prolong graft survival, thus demonstrating that peptide u-5 alone mediates the observed effects on graft prolongation. A total of 300 microg of u-5 injected IT combined with ALS led to acute rejection of third-party (Lewis) grafts. Intravenous injection of 300 microg of u-5 with ALS also did not prolong WF graft survival in ACI recipients. The long-term unresponsive ACI recipients accepted permanently donor-type (WF) but not third-party (Lewis) second-set cardiac and islet allografts. Similarly, we showed that although IT injection of 600 and 1200 microg of a mixture of immunogenic WAG-derived peptides 1, 2, and 5 combined with 0.5 ml of ALS on day -7 led to permanent WF graft survival in ACI, only IT injection of 300 microg of peptide 2 combined with ALS led to permanent graft survival (>150 days) in four of five animals. To define the underlying mechanisms of tolerance, we examined in vitro the mixed lymphocyte reaction (MLR), cell-mediated lymphocytotoxicity, and cytokine profile of unresponsive recipients. Although the results showed nonspecific T-cell suppression in the MLR at 25 days after transplantation, which correlated with the persistence of ALS immunosuppression, long-term unresponsive animals showed normal MLR to donor and third-party antigens. In contrast, the donor-specific reactive cytotoxic T lymphocytes remained suppressed in short-term and long-term unresponsive rats., Conclusion: Of interest is our finding that IT injection of a short segment of WAG-derived MHC class I peptide induces active acquired tolerance similar to results obtained with the use of pure WF-derived peptide u-5 in the WF-to-ACI rat combination. It is noteworthy that we could not confirm the T helper (Th)1/Th2 paradigm in this model by initial cytokine analysis. Whether induction of tolerance by IT injection of allo-MHC peptides will have clinical usefulness must await results of similar studies in large animals. However, of major interest is the finding that a short segment of RT1.AU represents the tolerogenic
- Published
- 1998
- Full Text
- View/download PDF
31. Clinical pattern of perforated prepyloric and duodenal ulcer at Ile-Ife, Nigeria.
- Author
-
Lawal OO, Fadiran OA, Oluwole SF, and Campbell B
- Subjects
- Adolescent, Adult, Female, Humans, Male, Middle Aged, Nigeria epidemiology, Postoperative Complications epidemiology, Retrospective Studies, Risk Factors, Duodenal Ulcer epidemiology, Duodenal Ulcer physiopathology, Duodenal Ulcer surgery, Peptic Ulcer Perforation epidemiology, Peptic Ulcer Perforation physiopathology, Peptic Ulcer Perforation surgery
- Abstract
High morbidity and mortality often attend perforation of duodenal ulcer. Over a 6-year period at Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria, 22 patients presented with prepyloric or duodenal ulcer perforations--a relatively low yearly rate of about four. Of the 15 patients evaluated, approximately three-quarters were working class young men and eight (53%) had no ulcer history. The high morbidity, and 20% mortality rate, observed were attributable to late presentation and the presence of advanced bacterial peritonitis in 67% of the patients at admission. Imprecise clinical features in those with small perforations led to misdiagnosis in a third of cases. Treatment of perforations in the majority (93%) of patients was by simple closure or truncal vagotomy and pyloroplasty. An increase in patients' awareness of the potentials of optimal operative management should encourage earlier presentation.
- Published
- 1998
- Full Text
- View/download PDF
32. Identification and morphology of rat islet allografts with dithizone after induction of donor-specific transplant tolerance by intrathymic administration of soluble antigen alloantigens.
- Author
-
Fiedor P, Garnuszek P, Maroszyńska I, Laskowski I, Licińska I, Mazurek AP, Oluwole SF, Rowiński W, and Hardy MA
- Subjects
- Animals, Diabetes Mellitus, Experimental immunology, Immune Tolerance, Rats, Rats, Inbred Lew, Rats, Wistar, Transplantation, Homologous, Diabetes Mellitus, Experimental surgery, Graft Rejection immunology, Islets of Langerhans Transplantation immunology, Isoantigens immunology, Thymus Gland immunology, Transplantation Immunology
- Published
- 1998
- Full Text
- View/download PDF
33. Monitoring of rat islet allografts with dithizone after induction of donor specific transplant tolerance by intrathymic administration of soluble alloantigens.
- Author
-
Fiedor PS, Jin MX, Zikria BA, Garnuszek P, Licińska I, Mazurek AP, Maroszyńska I, Piaseczna-Piotrowska A, Szymańska K, Rowiński WA, Hardy MA, and Oluwole SF
- Subjects
- Animals, Graft Survival, Isoantigens therapeutic use, Rats, Rats, Inbred Lew, Rats, Inbred WF, Thymus Gland, Dithizone, Indicators and Reagents, Islets of Langerhans Transplantation immunology, Isoantigens administration & dosage, Transplantation Immunology
- Abstract
Transplantation of whole pancreas or pancreatic islets remains a promising approach to treatment of diabetes mellitus. Since there is no efficient method presently known for in vivo detection of pancreatic islet rejection, we have utilized dithizone [DTZ] to monitor the survival of transplanted islet allografts following the induction of tolerance by a new strategy of deliberate introduction of donor antigens into the adult thymus. In this study, we examined the morphology of islet allografts in vivo and in vitro following pretreatment with intrathymic (IT) inoculation of 2 mg soluble Ag obtained from 3M KCl extracts of resting T-cells with or without ALS immunosuppression in the WF-to-Lewis combination. Fresh isolated rat islets stained pink 3-5 minutes following exposure to medium containing 0.12 mM DTZ solution in DMSO. Intravenous (i.v.) injection of DTZ solution into unmodified recipients of islet allografts that had rejected their grafts showed massive degranulation of islets which did not stain pink with DTZ. This was confirmed by microscopic finding of fibrosis and lymphocytic infiltration. In contrast, i.v. injection of DTZ solution into long-term recipients of islet allografts at 50, 100, and 150 days after transplantation showed viable islet cells which stained crimson red with DTZ and the findings were confirmed with microscopic sections. This study demonstrates that DTZ is an effective means of in vivo and in vitro identification of transplanted pancreatic islets and suggests that this strategy may have potential clinical application in the diagnosis of the pancreatic islet rejection.
- Published
- 1998
34. Evaluation of mitochondrial function after cold preservation of pancreatic islet cells from donors treated with pefloxacin.
- Author
-
Puc J, Kwiatkowski P, Bobrow M, Mrozek A, Juszczak M, Mazurek AP, Rowinski W, Oluwole SF, Hardy MA, and Fiedor P
- Subjects
- Adenosine, Allopurinol, Animals, Cell Survival, Coculture Techniques, Cold Temperature, Glucose pharmacology, Glutathione, Humans, Hypertonic Solutions, Insulin metabolism, Insulin Secretion, Interleukin-2 metabolism, Islets of Langerhans cytology, Islets of Langerhans drug effects, Lymphocytes immunology, Mitochondria drug effects, Organ Preservation Solutions, Raffinose, Rats, Rats, Inbred WF, Tumor Necrosis Factor-alpha metabolism, Pefloxacin, 4-Quinolones, Anti-Infective Agents, Fluoroquinolones, Islets of Langerhans physiology, Mitochondria metabolism, Quinolones pharmacology, Tissue Preservation methods
- Published
- 1997
- Full Text
- View/download PDF
35. Human immunodeficiency virus and lung cancer.
- Author
-
Alshafie MT, Donaldson B, and Oluwole SF
- Subjects
- Acquired Immunodeficiency Syndrome complications, Adult, Aged, Causality, Female, HIV Infections mortality, Humans, Lung Neoplasms mortality, Lung Neoplasms therapy, Male, Middle Aged, New York City epidemiology, Retrospective Studies, Risk Factors, Survival Rate, HIV Infections complications, Lung Neoplasms virology
- Abstract
Background: The association of human immunodeficiency virus (HIV) infection with lung cancer remains unclear. The presence of multiple risk factors in patients with HIV infection makes it difficult to identify a direct cause-effect relationship., Methods: A retrospective study of patients with lung cancer who were diagnosed, treated and followed at Harlem Hospital Center, New York, between January 1990 and December 1994 was performed. Eleven HIV-seropositive and 116 HIV-indeterminate patients with histologically proven lung cancer were identified. The two groups were compared with regard to age, sex, race, predisposing factors, stage of presentation, histological type of the tumours and survival., Results: HIV-infected patients with lung cancer were predominantly male smokers who were significantly younger than the control HIV-indeterminate patients with lung cancer. Although adenocarcinoma was seen more frequently in the HIV-seropositive group, the difference was not statistically significant. Survival in HIV-infected patients was shorter than that in HIV-indeterminate patients, suggesting that the cancer may be more aggressive in HIV-infected patients or that the progression of immunoincompetence in these patients may influence survival., Conclusion: A direct cause-effect relationship between lung cancer and HIV infection is difficult to establish in the presence of other risk factors, but the incidence of lung cancer may be increasing in HIV-infected men.
- Published
- 1997
36. Detection and morphologic evaluation of allotransplanted rat pancreatic islet cells.
- Author
-
Fiedor P, Szymanska K, Tomaszewska A, Socha K, Oluwole SF, Licińska I, Mazurek AP, Rowinski W, and Hardy MA
- Subjects
- Animals, Diabetes Mellitus, Experimental blood, Graft Rejection pathology, Islets of Langerhans Transplantation pathology, Islets of Langerhans Transplantation physiology, Neovascularization, Physiologic, Rats, Rats, Inbred Lew, Transplantation, Homologous, Blood Glucose metabolism, Diabetes Mellitus, Experimental surgery, Islets of Langerhans Transplantation methods
- Published
- 1997
- Full Text
- View/download PDF
37. Induction of tolerance to islet allografts in the high responder rat by intrathymic inoculation of soluble alloantigens.
- Author
-
Fiedor P, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Animals, Blood Glucose metabolism, Histocompatibility Antigens Class I biosynthesis, Islets of Langerhans Transplantation physiology, Rats, Rats, Inbred BN, Rats, Inbred Lew, Rats, Inbred WF, Thymus Gland immunology, Transplantation, Homologous, Diabetes Mellitus, Experimental therapy, Immunosuppression Therapy methods, Islets of Langerhans Transplantation immunology, Isoantigens administration & dosage, T-Lymphocytes immunology
- Published
- 1997
- Full Text
- View/download PDF
38. Importance of the relative resistance of cord blood CD34+ cells to UVB in bone marrow transplantation.
- Author
-
Yaron I, Jin MX, Oluwole SF, and Hardy MA
- Subjects
- Animals, Antigen-Presenting Cells immunology, Antigens, CD, Cell Survival radiation effects, Female, Fetal Blood immunology, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Humans, Placenta, Pregnancy, Rats, T-Lymphocytes immunology, Antigen-Presenting Cells radiation effects, Antigens, CD34, Bone Marrow Transplantation, Fetal Blood cytology, T-Lymphocytes radiation effects, Ultraviolet Rays
- Published
- 1997
- Full Text
- View/download PDF
39. Induction of transplant tolerance by intrathymic inoculation of synthetic MHC class I allopeptides.
- Author
-
Chowdhury NC, Murphy B, Sayegh MH, Hardy MA, and Oluwole SF
- Subjects
- Animals, Isoantigens administration & dosage, Peptide Fragments administration & dosage, Peptide Fragments chemical synthesis, Rats, Rats, Inbred ACI, Rats, Inbred WF, Thymus Gland, Graft Survival drug effects, Heart Transplantation immunology, Histocompatibility Antigens Class I immunology, Immunosuppression Therapy methods, Isoantigens pharmacology, Peptide Fragments pharmacology, T-Lymphocytes immunology
- Published
- 1997
- Full Text
- View/download PDF
40. Allograft rejection and corticosteroids in acute pancreatitis following renal and cardiac transplantation.
- Author
-
Hagopian EJ, Chabot JA, Oluwole SF, Benvenisty AI, and Hardy MA
- Subjects
- Acute Disease, Adult, Female, Graft Rejection immunology, Humans, Immunosuppressive Agents therapeutic use, Incidence, Male, Medical Records, Pancreatitis etiology, Retrospective Studies, Transplantation, Homologous, Adrenal Cortex Hormones therapeutic use, Graft Rejection epidemiology, Heart Transplantation immunology, Immunosuppression Therapy adverse effects, Kidney Transplantation immunology, Pancreatitis epidemiology, Postoperative Complications
- Published
- 1997
- Full Text
- View/download PDF
41. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
- Author
-
Fiedor P, Jin MX, Hardy MA, and Oluwole SF
- Subjects
- Animals, Histocompatibility Testing, Isoantigens administration & dosage, Major Histocompatibility Complex, Rats, Rats, Inbred BN, Rats, Inbred Lew, Rats, Inbred WF, Spleen, Thymus Gland, Transplantation, Homologous, Diabetes Mellitus, Experimental surgery, Graft Survival immunology, Immunosuppression Therapy methods, Islets of Langerhans Transplantation immunology, Isoantigens therapeutic use, T-Lymphocytes immunology
- Abstract
Recent studies suggest that the adult immune system can be manipulated by intrathymic (IT) inoculation of donor Ag to accept cardiac and islet allografts in the low responder rat combination of Lewis-to-WF. We have now extended this study to examine the effect of IT inoculation of soluble protein Ag obtained from 3M KCl extracts of resting T cells combined with transient ALS immunosuppression on islet allograft survival in the high responder combination of WF-to-Lewis. We first confirmed the earlier observation that IT injection of 2 mg soluble Ag on day -7 led to permanent islet graft survival (>200 days) in the Lewis-to-WF rat combination without the use of recipient immunosuppression and found this to be true in the Lewis-to-ACI rat combination. In the high responder combination of WF-to-Lewis, unmodified Lewis rats pretreated with IT inoculation of 2 mg soluble Ag acutely rejected WF and BN islet allografts. IT inoculation of donor Ag combined with 1 ml ALS transient immunosuppression on day -7 led to a modest graft prolongation [24.8+/-10.1 days as compared with 15.2+/-3.6 days in ALS only treated controls]. Intrathymic injection of soluble Ag on day -7 combined with 1 ml ALS on days -7 and 0 relative to allografting resulted in 100% permanent islet graft survival (>200 days) compared with an MST of 20.6+/-2.3 days in ALS only-treated controls. Similar treatment led to acute rejection of 3rd party (BN) grafts, thus demonstrating donor-specificity. In addition, extrathymic inoculation of donor Ag in similarly immunosuppressed animals did not result in islet graft prolongation, once again confirming the importance of the thymus in tolerance induction. To examine them for donor-specific tolerance, long-term unresponsive (>120 days) Lewis recipients of renal subcapsular islets underwent nephrectomy of the islet bearing kidneys and were challenged with intraportal donor- or third party-type islets after becoming diabetic. All the nonimmunosuppressed recipients of donor-type (WF) islets became permanently normoglycemic (>100 days) while the third-party (BN) grafts were promptly rejected, with an MST of 10.6 days. These findings confirm that acquired thymic tolerance induced by IT inoculation of soluble protein Ag in the low to moderate responder rat combinations is reproducible in the high responder combination provided that adequate peritransplant immunosuppression is used. This study suggests that acquired thymic tolerance in the rat model is dependent on host responsiveness to alloantigens, MHC differences between the donor-recipient pair, and the use of transient immunosuppression in the high responder recipient. This model may have potential clinical application in the development of strategies for specific transplantation tolerance.
- Published
- 1997
- Full Text
- View/download PDF
42. Acquired systemic tolerance to islet allografts induced by intrathymic inoculation of alloantigens--a brief review.
- Author
-
Oluwole SF, Chowdhury NC, Jin MX, and Hardy MA
- Subjects
- Animals, Isoantigens administration & dosage, Rats, Rats, Inbred ACI, Rats, Inbred BN, Rats, Inbred Lew, Rats, Wistar, Spleen immunology, T-Lymphocytes immunology, Thymus Gland, Diabetes Mellitus, Experimental surgery, Graft Survival immunology, Immunosuppression Therapy methods, Islets of Langerhans Transplantation immunology, Isoantigens therapeutic use
- Published
- 1997
43. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides.
- Author
-
Chowdhury NC, Murphy B, Sayegh MH, Jin MX, Roy DK, Hardy MA, and Oluwole SF
- Subjects
- Amino Acid Sequence, Animals, Graft Survival drug effects, Histocompatibility Antigens Class I chemistry, Injections, Intralymphatic, Molecular Sequence Data, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Rats, Inbred WF, Reoperation, Thymus Gland, Transplantation, Homologous, Heart Transplantation immunology, Immune Tolerance drug effects, Peptides immunology
- Abstract
This study extends the finding that intrathymic (IT) injection of 3M KC1 extracts of T cells induces transplant tolerance to the use of well defined polymorphic MHC class I allopeptides derived from the hypervariable domain of RT1.Au (WF MHC class I). While three of the six synthetic RT1.Au peptides were immunogenic, three others were nonimmunogenic when tested in ACI responders. In our initial studies, we examined the effects of IT injection of a mixture of equal concentrations of the three nonimmunogenic RT1.Au peptides on WF cardiac allograft survival in ACI recipients. The results showed that a single IT injection of 100 and 300 microg class I MHC allopeptides on day -7 relative to cardiac transplant did not significantly prolong graft survival in naive ACI recipients (MST of 9.8, and 12.3 days vs. 10.5 days in controls). In contrast, 600 microg allopeptides injected IT resulted in modest prolongation of graft to an MST of 19.5 days. However, IT injection of 600 microg allopeptides combined with 0.5 ml ALS on day -7 led to permanent acceptance (>200 days) of cardiac allografts in 7/9 ACI recipients compared with survival of 24.2 days in ALS alone treated controls. In contrast, similar treatment led to acute rejection of third party (Lewis) cardiac allografts. Intravenous injection of 600 microg allopeptides combined with ALS did not result in prolonged graft survival (26.8 days). The long-term unresponsive ACI recipients (>100 days) challenged with second-set cardiac grafts accepted permanently donor-type (WF) grafts while rejecting the third party (Lewis) grafts, a finding that confirms acquired systemic tolerance. These findings confirm the role of IT injection of synthetic polymorphic allopeptides in the induction of acquired thymic tolerance and provide the rationale for testing this strategy in large animals and eventually in man.
- Published
- 1996
- Full Text
- View/download PDF
44. A novel approach to in vivo visualization of human pancreatic islets.
- Author
-
Fiedor P, Wałaszewski J, Oluwole SF, Licińska I, Mazurek AP, Hardy MA, and Rowiński W
- Subjects
- Animals, Cadaver, Humans, Islets of Langerhans physiology, Islets of Langerhans Transplantation, Pancreas Transplantation, Rats, Dithizone, Islets of Langerhans cytology, Tissue Donors
- Published
- 1996
45. Localization of endocrine pancreatic islets.
- Author
-
Fiedor PS, Oluwole SF, and Hardy MA
- Subjects
- Animals, Blood Glucose metabolism, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Experimental surgery, Graft Rejection pathology, Humans, Infusions, Intravenous, Insulin metabolism, Insulin Secretion, Kidney surgery, Peritoneum surgery, Rats, Rats, Inbred Lew, Rats, Inbred WF, Transplantation, Homologous pathology, Chelating Agents, Diabetes Mellitus, Experimental pathology, Dithizone, Islets of Langerhans Transplantation pathology
- Abstract
Transplantation of whole pancreas or pancreatic islets remains a promising approach to treatment of diabetes mellitus. Because at present there is no efficient method for in vivo early diagnosis of pancreatic islet rejection or for disorders of pancreatic endocrine function, we examined if dithizone (DTZ) and a synthetic iodo-derivative of DTZ (I-DTZ) can be used as a potential radioactive marker for monitoring viable transplanted pancreatic islets. Human pancreatic islets harvested from multiorgan donors were tested ex vivo after intraductal injection of DTZ solution for islet staining. Lewis rats were used in the in vivo experiments for localizing pancreatic islets in situ after intravenous injection of various concentrations of DTZ or I-DTZ. Fresh rat islets were transplanted into streptozotocin-induced diabetic recipients, either underneath the kidney capsule or intraperitoneally. Intravenous DTZ or I-DTZ was then used for macroscopic and microscopic identification of viable transplanted islets. These studies indicate that DTZ and I-DTZ solutions specifically stain pancreatic islets in vivo after intravenous injection without damage to their endocrine function as assessed by plasma insulin and glucose levels. Human islets stain red in in vitro studies similar to the DTZ (I-DTZ) effect in rats. We conclude that DTZ and I-DTZ are effective in the in vivo and in vitro identification of pancreatic islets and may have potential clinical application in the detection of pancreatic islet tumors (insulinomas) and in the diagnosis of rejection of pancreatic organ allografts or islets.
- Published
- 1996
- Full Text
- View/download PDF
46. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
- Author
-
Gundlach M, Oluwole SF, Pohland CC, Broelsch CE, and Hardy MA
- Subjects
- Animals, Cytotoxicity, Immunologic, Graft Rejection immunology, Heart Transplantation physiology, Immunosuppression Therapy methods, Leukocytes radiation effects, Lymphocyte Transfusion, Rats, Rats, Inbred ACI, Rats, Inbred Lew, Time Factors, Graft Survival immunology, Heart Transplantation immunology, Intestine, Small transplantation, Leukocyte Transfusion, Transplantation, Homologous immunology, Ultraviolet Rays
- Published
- 1996
47. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens.
- Author
-
Shimomura K, Hardy MA, and Oluwole SF
- Subjects
- Animals, Antilymphocyte Serum therapeutic use, Isoantigens administration & dosage, Rats, Rats, Inbred BN, Rats, Inbred Lew, Rats, Inbred WF, Thymus Gland, Graft Survival, Heart Transplantation immunology, Immunosuppression Therapy methods, Isoantigens pharmacology, Lymphocyte Transfusion, T-Lymphocytes
- Published
- 1996
48. In vitro evaluation of neonatal human immunity against the pig.
- Author
-
Xu H, Oluwole SF, Edwards NM, Chen JM, Naka Y, Kim E, and Michler RE
- Subjects
- Adult, Animals, Antibodies, Heterophile analysis, Aorta immunology, Endothelium, Vascular immunology, Enzyme-Linked Immunosorbent Assay, Humans, Immunoglobulin G analysis, Immunoglobulin M analysis, Lymphocytes immunology, Infant, Newborn immunology, Swine immunology, Transplantation, Heterologous
- Abstract
The critical shortage of organ donors has greatly limited the number of clinical allotransplantations. This is particularly true for neonatal patients, for whom xenotransplantation could provide an alternative therapeutic option to allotransplantation. The role of neonatal infant immunity in xenotransplantation is not, however, clearly understood. We examined both the proliferative responses of human neonatal lymphocytes to pig aortic endothelial cells and serum levels of neonatal natural antipig xenoantibody. Neonatal human lymphocytes and serum were isolated from umbilical cord blood. Adult human lymphocytes and serum were used as controls. A one-way xenogeneic mixed lymphocyte-endothelial cell reaction was performed, and lymphocyte proliferation was measured by tritiated thymidine uptake. Neonatal human lymphocytes recognized and proliferated in response to pig aortic endothelial cells (mean 63,926 +/- 26,054 counts per minute). The level of xenogeneic mixed lymphocyte-endothelial cell reaction of neonatal lymphocytes was significantly lower (p < 0.004) than that of adult human lymphocytes (mean 122,444 +/- 33,132 counts per minute). An enzyme-linked immunosorbent assay was performed to determine the binding of natural immunoglobulin M and G antibodies to pig endothelial cells. Whole-cell enzyme-linked immunosorbent assay demonstrated neonatal human serum to contain very low binding levels of natural antipig immunoglobulin M xenoantibody compared with adult serum. Like adult serum, neonatal human serum contained natural antipig immunoglobulin G xenoantibody. Neonatal serum was not cytotoxic to pig endothelial cells, suggesting that immunoglobulin G was not the predominant xenoreactive antibody. To assess whether neonatal pig endothelial cells also expressed xenoantigens, adult and neonatal cultured pig endothelial cells were examined by enzyme-linked immunosorbent assay with adult human serum. Adult human natural immunoglobulin M xenoantibody recognized not only adult pig endothelial cell xenoantigens but also neonatal pig endothelial cell xenoantigens. The binding levels of adult natural antipig immunoglobulin M xenoantibodies to adult and neonatal pig endothelial cells were similar, suggesting that neonatal pig aortic endothelial cells express xenoantigens. The findings of low binding levels of cytotoxic antipig immunoglobulin M xenoantibody and low levels of lymphocyte xenoreactivity to pig endothelial cells in human neonates suggests that pig organs may eventually be a suitable source of xenografts for human neonates.
- Published
- 1996
- Full Text
- View/download PDF
49. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
- Author
-
Yaron I, Yaron R, Oluwole SF, and Hardy MA
- Subjects
- Apoptosis drug effects, Clonal Anergy drug effects, Clonal Anergy radiation effects, Cytotoxicity, Immunologic drug effects, Cytotoxicity, Immunologic radiation effects, DNA Damage, Humans, Lymphocyte Activation drug effects, Lymphocyte Activation radiation effects, Lymphocyte Culture Test, Mixed, Lymphocytes drug effects, Lymphocytes immunology, T-Lymphocyte Subsets drug effects, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets radiation effects, Apoptosis radiation effects, Azathioprine pharmacology, Cyclosporine pharmacology, Graft vs Host Disease prevention & control, Immunosuppression Therapy methods, Immunosuppressive Agents pharmacology, Lymphocytes radiation effects, Methylprednisolone pharmacology, Ultraviolet Rays
- Abstract
UVB irradiation of bone marrow or pancreatic islets has been shown to prevent GVHD and to induce transplant tolerance in experimental animal models. To clarify the underlying mechanism(s) responsible for these UVB effects we have examined in vitro cell function following UVB irradiation using LDA, FACS analysis, and DNA gel electrophoresis to assess the role of UVB-induced anergy and/or cell death. To extend our studies to the clinical setting and to promote chimerism and tolerance to organ allografts, we have further studied the effects of UVB irradiation combined with the commonly used immunosuppressive agents (cyclosporine, azathioprine, and methylprednisolone) on human T cells in proliferative in vitro assays. When cytotoxic and proliferative responses to allogeneic cells or to PHA stimulation were evaluated in LDA, the use of increasing doses of UVB irradiation resulted in a dose-dependent decrease in proliferative and cytotoxic responses of T-cells as seen by decreases in precursor frequencies. The results of proliferative T-cell assays suggest an additive immunosuppressive effect of various immunosuppressive drugs when combined with UVB irradiation. Gel electrophoresis of DNA derived from resting and activated, UVB-irradiated PBLs showed apoptosis at all UVB doses used. FACS analysis of UVB-treated CD2+ cells resulted in a UVB dose-related decrease in cell numbers that correlated with viability studies. It appears that UVB irradiation of both activated and resting PBLs induces programmed cell death but not anergy of T-cells.
- Published
- 1996
- Full Text
- View/download PDF
50. UVB-irradiation of human bone marrow: potential for donor specific tolerance.
- Author
-
Noizat-Pirenne F, Greenfeld JI, Hardy MA, Oluwole SF, De Groote D, and Franchimont P
- Subjects
- Cell Division radiation effects, Colony-Forming Units Assay, Cytokines biosynthesis, Humans, Leukocyte Count radiation effects, Lymphocyte Culture Test, Mixed, Monocytes cytology, Monocytes metabolism, Monocytes radiation effects, Phytohemagglutinins pharmacology, T-Lymphocytes cytology, Bone Marrow radiation effects, Immune Tolerance, Tissue Donors, Ultraviolet Rays
- Abstract
Bone marrow mononuclear cell (BMMC) transplant may serve to produce donor specific tolerance for a coincident solid organ graft, but with the risk of graft versus host disease (GVHD). We examined in vitro the immunomodulatory effect of UVB on human BMMCs as potential prophylaxis against GVHD for clinical transplantation. After 10-200 J/m2 UVB-irradiation, BMMCs were examined by proliferative response (in mixed lymphocyte reaction and following phytohemagglutinin stimulation) and by cytokine profile. We also evaluated CFU-GM, CFU-GEMM, and BFU-E progenitor viability by 2-week methyl cellulose cultures following UVB-irradiation. Parallel studies were applied to marrow that was T-cell depleted by soybean agglutination (SBA) or by SBA and sheep erythrocyte rosetting (SBA-E-). We found that (1) UVB produces a dose-dependent inhibition of the proliferative response to stimulators by human BMMCs; (2) increasing doses of UVB-irradiation and increasing levels of T-cell depletion (TCD) are both inversely related to production of lymphokines (IL2, IL3, LIF, IFN-gamma, and GMCSF) and (3) T-cell depletion, but not UVB-irradiation, decreases the production of monokines (IL1, TNF, IL6). Progenitor cell viability was decreased but preserved at 100 J/m2 of UVB. Our findings suggest that UVB compares favorably with TCD as a technique for inhibition of GVHD and therefore that UVB-modulation of bone marrow (BM) inoculum may be useful in the prevention of GVHD in clinical bone marrow transplantation accompanying a solid organ graft.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.